Myeloid cell leukemia sequence-1 (Mcl-1) is a critical anti-apoptotic factor in T lymphocytes. However, in spite of the many pro-apoptotic proteins with proposed binding to Mcl-1, the specific interactions by which Mcl-1 regulates primary T-cell survival under different conditions have not been fully explored. Further, how different trophic cytokines modulate the specific role(s) of Mcl-1 is unknown. Here, we use genetic mouse models to dissect the roles of Mcl-1 in primary T lymphocytes. Using the inducible Mcl-1-floxed estrogen receptor-Cre fusion protein f/f ERCre) deletion system in combination with genetic modification of other B-cell lymphoma 2 (Bcl-2) family members, we show that loss of pro-apoptotic Bcl-2 homologous antagonist/killer (Bak) rescues the survival of Mcl-1-deficient T cells in the presence of IL-7. Without IL-7, the survival of Mcl-1-deficient cells cannot be rescued by loss of Bak, but is partially rescued by overexpression of Bcl-2 or loss of Bcl-2-interacting mediator of cell death (Bim). Thus, Mcl-1 and Bcl-2 have a shared role, the inhibition of Bim, in promoting T-cell survival during cytokine withdrawal. Finally, we show that other common gamma-chain (cc) cytokines differentially modulate the roles of Mcl-1. IL-15 has effects similar to those of IL-7 in memory T cells and naïve CD8 þ cells, but not naïve CD4 þ cells. However, IL-4 maintains Mcl-1 and Bcl-2 but also upregulates Bim and Bcl-2-associated X protein (Bax), thus altering the cell's dependence on Mcl-1. Cell Death and Disease (2011) 2, e214; doi:10.1038/cddis.2011.95; published online 6 October 2011
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Upon activation, T cells expand into effector populations before 'contracting' into antigen-experienced ('memory') populations that are retained over time. Unlike naïve cells, memory cells do not require self-peptide-MHC and can utilize IL-15 for survival. 1 IL-7 and other cytokines, namely IL-2, IL-15, IL-4, IL-9, and IL-21, constitute a family that shares the gc-receptor subunit. The cytokine receptors are composed of the gc subunit with one or two other subunit(s), some shared and some unique. Each cytokine has a distinct biological role, although several of them, particularly IL-7 and IL-15, promote T-cell survival. 2 Studies from mice, primary cells, and cell lines have implicated the B-cell lymphoma-2 (Bcl-2) family, specifically the Bcl-2/Bcl-2-interacting mediator of cell death (Bim)/Bcl-2-associated X protein (Bax) axis, downstream of cytokine signaling, 3 but the role of myeloid cell leukemia sequence-1 (Mcl-1) in cytokine-induced survival is less well described.
The Bcl-2 family proteins are defined as sharing one or more Bcl-2 homology (BH) domains. Pro-apoptotic Bcl-2 homologous antagonist/killer (Bak) and Bax self-oligomerize to form pores in mitochondrial membranes, and are required for the intrinsic pathway of apoptosis. 4, 5 Pro-apoptotic BH3-only proteins, such as Bim, Bid, Bad, Noxa, and Puma, are upstream initiators. Anti-apoptotic proteins, including Bcl-2, Mcl-1, and Bcl-x L , have been proposed to function both by inhibiting the BH3-only proteins and by inhibiting Bak/Bax. [6] [7] [8] [9] [10] [11] Which of these roles is dominant has been debated and has not been thoroughly explored in vivo.
Knockout mouse models have demonstrated the importance of Bcl-2 family proteins in T-lymphocyte survival. Bak/Bax double-knockout mice, but not single-knockouts, exhibit increased numbers of T cells, T-cell resistance to apoptosis, and defective thymic selection. 12, 13 Both Bcl-2 and Mcl-1 are required for survival in developing thymocytes and mature T cells. [14] [15] [16] [17] [18] Inhibition of Bak by Mcl-1 is critical in thymocytes: Bak deficiency, but not Bax deficiency or Bcl-2 overexpression, rescued the phenotype of Mcl-1-deficient thymocytes. 19 Although Bim is important in thymocyte negative selection, and the Bim À/À background rescued Bcl-2-deficient thymocyte survival, [20] [21] [22] Bim deficiency did not improve survival in Mcl-1-deficient thymocytes. 19 Peripheral T cells die upon drug-induced deletion of Mcl-1 in vivo and under different in vitro conditions. 17, 18 However, the mechanism(s) by which Mcl-1 promotes peripheral T-cell survival and the effect, if any, of trophic cytokines on these mechanisms are not yet understood. In this study, we utilize genetic models to investigate the mechanisms by which Mcl-1 promotes peripheral T-lymphocyte survival. We examine the survival of Mcl-1-deficient cells on Bak
, and Bcl-2-overexpressing backgrounds in the presence and absence of IL-7 and other gc-sharing cytokines. The data highlight the complex pathways that regulate primary T-cell survival, particularly the role of Mcl-1, and the functions of gc cytokines.
Results

Mcl-1 is required for CD4
þ and CD8 þ , naïve and memoryphenotype T-cell survival. The estrogen receptor-Cre fusion protein (ERCre) allows deletion of floxed genes upon addition of the drug tamoxifen, or its active metabolite 4-hydroxytamoxifen (4OHT). 23 We previously showed that 4OHT-treated T cells from Mcl-1-floxed, ERCre-expressing (Mcl-1 f/f ERCre) mice died under different ex vivo conditions. 18 As in vivo studies using this model were precluded by rapid morbidity in tamoxifen-treated Mcl-1-floxed estrogen receptorCre fusion protein (Mcl-1 f/f ERCre) mice, we used the in vitro system to dissect the individual and combinatorial effects of Bcl-2 family proteins and trophic cytokines on Mcl-1 activity.
To assess whether Mcl-1 deletion differentially affects T-cell subsets, we examined survival in Mcl-1-deleted T-cell subsets. To assess the effect of IL-7, we added IL-7 to 1 ng/ml, a concentration that is commonly used in T-cell biology, and that is thought to be physiological. Similar to previous results, 18 CD4 þ and CD8 þ Mcl-1 f/f ERCre T-cells had reduced survival upon Mcl-1 deletion in a 3-day culture of splenocytes in medium alone, with IL-7 ( Figure 1a) , and with activating anti-CD3/CD28 antibodies (data not shown).
As baseline survival varied between conditions, we calculated the ratio of survival with 4OHT to survival with vehicle control (ethanol, EtOH) to have a better comparison of the effect of Mcl-1 deletion. The magnitude of the reduction in survival upon deletion is a measure of Mcl-1 dependency. The 4OHT/EtOH survival ratio was approximately 1 in ERCrenegative samples (Figure 1b 
Bak
À/À rescues Mcl-1-deficient T-cell survival in IL-7, but not during cytokine withdrawal. In a previous study, Bak deficiency rescued Mcl-1-deficient thymocyte survival, and we observed rescued T-cell numbers in Bak
CD4Cre spleens. 19 To determine the importance of Bak inhibition in peripheral T cells, we compared 19, 25, 26 To determine whether Bcl-2 modulates Mcl-1-deficient peripheral T-cell survival, we used mice expressing a Bcl-2 transgene using the MHC class-I promoter (Bcl-2 tg mice). 27 Bcl-2 overexpression rescued undeleted T-cell survival in medium alone to the levels observed with IL-7 ( Figure 3a) . We observed a slight improvement over wild-type cells in Bax À/À but not Bak 
Bim
À/À partially rescues T-cell cytokine dependency, but not the requirement for Mcl-1. Bim has been shown to be induced by cytokine withdrawal, and to modulate T-cell cytokine dependency. 28, 29 We observed that Bim þ T cells to a similar extent as IL-7 ( Figure 5a ). CD44 lo CD4 þ T cells were not responsive to IL-15: the percent survival with 1 ng/ml IL-15 was similar to that in RPMI (slightly higher with 10 ng/ml, Figure 5a ). These results are consistent with a well-documented difference in responsiveness to IL-15 between subsets, and could be due to receptor expression levels. [32] [33] [34] The diminished survival upon Mcl-1 deletion (measured by the 4OHT/EtOH survival ratio) was more severe in IL-4 than in IL-7, indicating that cells cultured in IL-4 were more sensitive to Mcl-1 deletion (Figure 5c ). The survival ratio in IL-4 was not significantly different from that in RPMI alone. With IL-15, sensitivity to Mcl-1 deletion correlated to the overall response to IL-15: non-responsive CD44 lo CD4 þ cells were more sensitive than IL-15-responsive CD44 Modulation of Bcl-2 family proteins by cc cytokines. To determine why T cells cultured in IL-4, IL-7, and IL-15 had differing levels of dependence on Mcl-1, we examined protein expression for selected Bcl-2 family members upon culture with different gc cytokines. IL-4, IL-7, and IL-15 induced higher expression of Mcl-1 and Bcl-2 than IL-2 or RPMI on day 3 (Figures 6a and b) . Surprisingly, Bim was upregulated in the pro-survival cytokines, and this upregulation was most pronounced in IL-4 (Figures 6a  and b) . The upregulation of Bim by IL-4 was also observed on day 1 by intracellular staining (data not shown) and to a Cytokine-dependent and -independent roles for Mcl-1 A Dunkle et al modest extent (increase of B20%) by western blotting (Figure 6c) . We examined the expression of Bak and Bax by western blotting (day 1 was selected because of the low cell survival by day 3 in some conditions). Bak levels were slightly higher in pro-survival cytokines but were equivalent between cytokines. Bax expression was highest in IL-4, indicating another mechanism that could explain the increased sensitivity of cells in IL-4 to Mcl-1 deletion. However, because of the surprising induction of Bim by prosurvival cytokines, the relative induction of Bim (normalized to RPMI) was measured by flow cytometry in CD44 lo and CD44 This group demonstrated that expression of sufficient Bcl-2 to neutralize the Bim is critical in effector/memory T-cell survival. 36 As Mcl-1 is also expressed in effector and memory T cells, 18 the specific activity of Mcl-1 likely influences the effective balance of Bcl-2 and Bim in these cells. The balance between the specific and shared functions of Mcl-1/Bcl-2 may be critically important for regulating memory. Depending on the identity and concentration of cytokines present, Mcl-1 will be more or less necessary to enhance Bcl-2 activity. As IL-4, which is produced during a Th2-polarized immune response, skews the primary role of Mcl-1 toward inhibiting the Bim/Bax pathway, the susceptibility of T-cell subsets to apoptosis in Th1 versus Th2 conditions should be closely examined. As methods of detection continue to improve, it will be important to determine the precise local concentrations of cytokines in different niches, such as in circulation, or within lymphoid organs. Combined with our data, this will allow a better understanding of the processes that regulate cell survival in vivo.
In addition to the implications of our data on normal T-cell biology, the role of Mcl-1 and the skewing of the apoptotic pathway by different cytokines could potentially be important in tumor biology. The Bcl-2-family proteins are frequently disregulated during oncogenesis, including that of the lymphoid system. The drug ABT-737, a synthetic inhibitor of Bcl-2, Bcl-x L , and Bcl-w, is a potent antitumor agent. 37 As ABT-737 does not inhibit Mcl-1, tumor cell resistance to ABT-737 correlates with Mcl-1 levels. 38, 39 Intriguingly, factors such as cytokines may influence the extent to which tumor cells depend on the Mcl-1/Bcl-2 shared versus unique pathway of survival. Although tumor immunity is typically associated with cytotoxic T-cell responses, the skewing of the apoptotic pathway toward the shared Bim/Bax pathway by IL-4 has interesting implications on how a Th2 response or IL-4 alone might indirectly promote tumor cell death. It is possible that this pathway could be manipulated therapeutically to enhance the efficacy of apoptotic drugs, such as ABT-737, that preferentially trigger the Bak or the Bim/Bax apoptotic pathway.
Materials and Methods
Mice. Mcl-1 f/f mice were generated as described previously and were backcrossed at least seven generations onto the C56BL/6 strain background. 40 The in vitro deletion of Mcl-1 was achieved using the inducible knockout system in which ERCre is expressed from the Rosa26 gene locus. 23 Bak
, and Bim À/À mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Bcl-2 tg mice 27 were provided previously by Dr. Motonari Kondo. Mice were maintained in specific pathogen-free conditions, and were utilized under protocols approved by the Duke University Institutional Animal Care and Use Committee.
Antibodies, cytokines, and other reagents. The antibodies used for sorting and surface staining for flow cytometry (against CD4, CD8, CD44, and TCRb) were obtained from Biolegend (San Diego, CA, USA). Rabbit anti-Bak, -Bax, -Bim, and -b-tubulin, as well as the horseradish peroxidase (HRP)-conjugated anti-rabbit antibody were from Cell Signaling Technology (Danvers, MA, USA). Rabbit anti-Mcl-1 was from Rockland Immunochemicals (Gilbertsville, PA, USA). The whole rabbit IgG isotype control and phycoerythrin (PE)-anti-rabbit IgG were from Jackson Immunoresearch (West Grove, PA, USA). The PE-conjugated Bcl-2 staining kit was obtained from BD Biosciences (San Jose, CA, USA). Murine IL-7, IL-4, and IL-15 were purchased from Peprotech (Rocky Hill, NJ, USA), and were dissolved according to the manufacturer's instructions. Cytokines were then diluted to 1000 Â stocks in medium (RPMI) and stored at À801C until use. Recombinant hIL-2 was obtained from the Duke University Pharmacy (Durham, NC, USA) and was diluted to a stock concentration of 10 5 units (U)/ml in medium and stored at 41C. 4OHT was obtained from Sigma (St. Louis, MO, USA), and was dissolved in 100% EtOH to a stock concentration of 500 mM. Propidium iodide (PI) was obtained from Sigma and was dissolved in phosphate-buffered saline (PBS) to a 500 Â stock concentration of 1 mg/ml. All the media and its related solutions were from Invitrogen (Carlsbad, CA, USA).
Total splenocyte cultures and deletion of Mcl-1. Spleens were smashed and filtered through a nylon mesh to make a single-cell suspension in Cytokine-dependent and -independent roles for Mcl-1 A Dunkle et al PBS. Red blood cells (RBCs) were lysed using ACK buffer for 1-2 min at room temperature, and the remaining cells were washed, counted, and resuspended in complete RPMI ( þ 10% fetal bovine serum (FBS) and 1 Â non-essential amino acids, L-glutamine, and penicillin/streptomycin) to a concentration of 2-4 Â 10 6 cells/ml. Although the cell concentrations used varied slightly between different experiments, the cell concentrations of the different samples were kept constant within each experiment. A total of 100 ml of cells was plated in triplicate onto 96-well Corning Costar plates with an equal volume of complete RPMI containing 4OHT or EtOH and cytokines as appropriate (final cell concentration was 1-2 Â 10 6 cells/ml). 4OHT was used at a final concentration of 100 nM, and the EtOH vehicle control was prepared by adding an equivalent volume of 100% EtOH to the control medium. The final concentration of IL-7 was 1 ng/ml, the concentration of hIL-2 was 100 U/ml, and the concentrations of IL-15 and IL-4 were both 10 ng/ml, unless otherwise indicated in the figure. Cells were cultured in a 5% CO 2 , 371C humidified atmosphere for 1, 3, or 5 days before analysis. Unless otherwise indicated, the data shown are from a 3-day culture of the cells.
Sorting of CD44
hi and CD44 lo cells. For experiments using sorted T cells, splenocytes as well as mesenteric and inguinal lymph nodes were collected, and RBCs were lysed as described above. Cells were resuspended in 2% FBS in PBS for T-cell enrichment before sorting. T cells were enriched using the EasySep T-Cell Enrichment Kit (Stem Cell Technologies, Vancouver, BC, Canada), following the manufacturer's instructions. Cells were surface stained and sorted into CD44-high (CD44 hi ) and CD44-low (CD44 lo ) populations on a FACSDiva (BD Biosciences) or MoFlo (Beckman Coulter, Miami, FL, USA) cell sorter. To increase the plating density of sorted cells, CD4
þ and CD8 þ cells were cultured together within the CD44 hi and CD44 lo populations. Cells were cultured as described above, except with cell concentrations of 0.1-1 Â 10 6 cells/ml.
Flow cytometry and measurement of cell survival. Cells were transferred into a U-bottom 96-well plate, centrifuged, and resuspended in 25% 24G2 hybridoma supernatant (Fc block) in 2% FBS. After a 10-15 min blocking step, cells were stained with antibodies to surface molecules for 15-30 min. Cells were washed with 2% FBS, and were resuspended in 2% FBS containing PI at 2 mg/ml. Cells were kept on ice throughout the staining, and until analysis on a FACSCanto cytometer (BD Biosciences). Flow cytometry data were analyzed using FlowJo software (Tree Star Inc., Ashland, OR, USA). Events were initially gated on live and dead cells (and 'debris' was removed) based on forward and side scatter (FSC and SSC). Then CD4 þ TCRb þ and CD8 þ TCRb þ populations were gated (in some cases with the addition of the marker CD44), and the percentage of cells in each population that was negative for PI staining was determined.
Intracellular staining for Mcl-1, Bcl-2, and Bim. T cells were enriched as described above using the EasySep T Cell Enrichment Kit (Stem Cell Technologies), following the manufacturer's instructions. Cells were plated in a 96-well plate at a density of 1-2 Â 10 6 cells/ml in the presence of IL-2 (100 U/ml), IL-4 (10 ng/ml), IL-7 (1 ng/ml), or IL-15 (10 ng/ml) or without cytokine. After 3 days in culture, cells were surface-stained as described above, fixed in 1% paraformaldehyde on ice for 20 min, and stored at 41C overnight. Cells were permeabilized with 0.1% saponin in 2% FBS. For the Mcl-1 and Bim stains, the permeabilization buffer contained 5% donkey serum and 10% 24G2 supernatant. After permeabilization, cells were centrifuged and resuspended in 90 ml of the same buffer. PE-anti-Bcl-2 and the corresponding isotype control were added at 10 ml/stain as per the manufacturer's recommendation. Stock solutions of anti-Mcl-1 (0.1 mg/ml in 50% glycerol in PBS) and anti-Bim (0.234 mg/ml in 50% glycerol) were diluted so as to add 10 ml of the diluted antibody solution to yield a final dilution of 1 : 100 (Mcl-1) or 1 : 200 (Bim). For the isotype controls, stock solutions of rabbit IgG were prepared to equivalent concentrations in 50% glycerol in PBS, and were diluted and added to the appropriate wells accordingly. For each condition, one well was stained with each isotype control and duplicate wells were used for each of the specific antibody stains. After primary antibody staining, cells were washed in 0.1% saponin two times, and cells for the Mcl-1 and Bim stains, as well as the isotype controls, were incubated in PE-anti-rabbit IgG (1 ml/well) in 0.1% saponin. Cells were washed two times and were analyzed immediately using a FACSCanto cytometer (BD Biosciences). For the subsequent analysis, only those cells in the 'live' gate by forward and side scatter were used.
To assess Mcl-1 deletion in the different genotypes by measuring Mcl-1 protein levels, splenocytes were cultured under the same conditions used to assess survival. The Mcl-1 staining was performed as described above. The cell-survival data for each experiment in which Mcl-1 staining was performed were confirmed to represent a typical experiment for that genotype. To determine whether the doubleknockout cells rescued the survival of Mcl-1-deficient cells by selecting for undeleted cells, the Mcl-1 protein levels were compared between knockout and wild-type cells for Bak, Bim, and Bak with and without the deletion of Mcl-1. To do this, the mean fluorescence intensities (MFIs) of duplicate Mcl-1-stained wells were averaged, and divided by the MFI of the isotype control well for each condition and cell type to obtain a value for Mcl-1 expression. Then, the ratio of the Mcl-1 expression level in knockout (Bak, Bim, or Bax) cells to that in wild-type cells was calculated to determine if any increase in expression over wild-type could be observed in the knockout.
Western blotting. Enriched T cells were prepared as described and were plated onto six-well plates at a density of 2 Â 10 6 cells/ml (6 ml, 12 Â 10 6 cells/well) in the presence or absence of cytokines. After 1 day (24 h), the cells were collected into 15-ml conical tubes, washed with PBS, and resuspended in 150 ml of SDS sample buffer (50 mM Tris HCl, pH 6.8 and 2% SDS) containing 20 mM freshly added dithiothreitol (DTT). Cells were lysed on ice for 30 min, then 30 ml of 6 Â sample buffer containing bromophenol blue and glycerol (at final concentrations of 0.1% and 10%, respectively) was added, and samples were boiled for 5 min. Protein lysate aliquots were stored at À801C until use. For 'fresh' T cells, an equal number of cells were lysed immediately after T-cell enrichment, and the sample was prepared and stored as described. Protein samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to a polyvinylidene fluoride (PVDF) membrane (ImmobilonP; Millipore, Billerica, MA, USA). To allow simultaneous staining of Bak, Bax, or Bim and the loading control (b-tubulin), the membranes were cut at the 37-kDa marker, and the top half was used for b-tubulin, while the bottom half was used for the Bcl-2 family protein. The membranes were blocked with 5% milk in PBS-T (PBS containing 0.2% Tween-20) at room temperature with gentle shaking for 45 min, followed by incubation in primary antibodies (all used at 1 : 1000 in 3% bovine serum albumin (BSA) in PBS-T) for 1-1.5 h also at room temperature with gentle shaking. After washing in PBS-T (3 Â 10 min), the HRP-conjugated anti-rabbit secondary antibody was added (1 : 5000 in 3% BSA in PBS-T), and the membranes were gently shaken at room temperature for 1 h. The membranes were washed (3 Â 10 min in PBS-T) and incubated in the SuperSignal West Pico Substrate (Pierce/Thermo Scientific, Rockford, IL, USA) for 5 min before the signal was detected by exposure to film.
Image analysis for western blotting. To estimate the relative intensities of the Bak, Bax, and Bim bands, corrected by the b-tubulin loading control bands, the gel analysis tools of the ImageJ software (http://rsbweb.nih.gov/ij/) were used. For each blot, a histogram was plotted for the signal in each lane, and the peak corresponding to the band was defined by drawing a line across the bottom of the peak based on the signal in the background region. The area under the peak was calculated relative to Lane 1 (fresh T cells, arbitrarily set to 1). To correct for slight differences in protein loading, the relative intensity of Bak, Bax, or Bim was divided by the relative intensity of the corresponding b-tubulin band to yield a loadingcorrected estimated intensity of Bak, Bax, or Bim relative to Lane 1. ). To compare survival between genotypes (as in Figure 5e ) the ratio of the survival of Bcl-2 tg or Bax À/À cells to that of Bcl-2/ Bax wild-type cells from the same experiment (all on the Mcl-1 f/f ERCre background) was calculated for each condition, and the S.D. ratio was used. To combine multiple experiments, the 4OHT/EtOH survival ratios of the individual experiments were averaged, and the mean plus standard error of the mean (S.E.M.) are depicted in the figures. To assess statistical significance, an unpaired Student's t test was used, and P-values less than 0.05 were considered to be significant. For some figures (as indicated in the legends), a 'graded' indication of significance is depicted using the following symbols: *Po0.05; **Po0.01; and ***Po0.001.
